- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Skye Bioscience Inc (SKYE)
Skye Bioscience Inc stock price live, this page displays NASDAQ SKYE stock exchange data. View the SKYE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Skye Bioscience Inc real time stock price chart below.
What Is the Skye Bioscience Inc Stock Price Today?
The Skye Bioscience Inc stock price today is 0.8152.
What Is the Stock Symbol for Skye Bioscience Inc?
The stock ticker symbol for Skye Bioscience Inc is SKYE.
Is SKYE the Same as $SKYE?
$SKYE is a common way to refer to the Skye Bioscience Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Skye Bioscience Inc Trade On?
Skye Bioscience Inc is listed and trades on the NASDAQ stock exchange.
Is Skye Bioscience Inc a Good Stock to Buy?
Determining whether Skye Bioscience Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Skye Bioscience Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SKYE quote. (ISIN: US83086J2006)
What Is the Skye Bioscience Inc Stock Price Today?
The Skye Bioscience Inc stock price today is 0.8152.
What Is the Stock Symbol for Skye Bioscience Inc?
The stock ticker symbol for Skye Bioscience Inc is SKYE.
Is SKYE the Same as $SKYE?
$SKYE is a common way to refer to the Skye Bioscience Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Skye Bioscience Inc Trade On?
Skye Bioscience Inc is listed and trades on the NASDAQ stock exchange.
Is Skye Bioscience Inc a Good Stock to Buy?
Determining whether Skye Bioscience Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Skye Bioscience Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SKYE quote. (ISIN: US83086J2006)
0.8152
0.0000(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.7178
0.8297
52 wk Range
0.5655
5.7500
SKYE is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.71780.8297
52 wk Range
0.56555.7500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SKYE Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
8.2500
Upside
+912.02%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings downwards for the upcoming period
- Form 8K Skye Bioscience Inc For: 19 March
- Investing.com
- Form 8K SKYE BIOSCIENCE For: 3 April
- Investing.com
- Form 8K SKYE BIOSCIENCE For: 3 April
- Investing.com
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
Skye Bioscience Inc SWOT Analysis
Financial Outlook | Analyst price targets range from $14 to $15, with Skye's $59.2M cash position supporting operations through Q1 2027 despite current unprofitability |
Market Potential | With a growing obesity epidemic, Skye Bioscience targets a substantial market opportunity, competing against established players in the pharmaceutical industry |
Safety Edge | Nimacimab's peripherally restricted design aims to avoid neuropsychiatric side effects, a common issue with previous CB1 inhibitors |
Obesity Breakthrough | Skye Bioscience's nimacimab shows promise in preclinical trials, potentially revolutionizing weight management with its unique CB1 inhibitor mechanism |
Skye Bioscience Inc Earnings Call Summary for Q4/2025
- Skye Bioscience ended 2025 with $25.7M in cash, extending operational runway through Q4 2026 via disciplined capital allocation.
- CBeyond trial demonstrated significant weight loss when nimacimab combined with semaglutide, targeting second-line obesity treatment market.
- Company advancing Antibody-Peptide Conjugate program alongside CB1 antibody nimacimab to simplify dosing regimens for obesity therapy.
- Four analysts revised earnings upward; InvestingPro rates financial health 'GREAT' at 3.65 despite pre-revenue clinical-stage status.
- Key risks include FDA regulatory hurdles for combination therapies, funding constraints, and competition from established GLP-1 treatments.
Last Updated: 03/10/2026, 05:35 PM
Read Full TranscriptSkye Bioscience investor slides for Q4/2025
Last Update: Mar 10, 2026
See full investor slides
Compare SKYE to Peers and Sector
Metrics to compare | SKYE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSKYEPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −2.5x | −0.5x | |
PEG Ratio | 0.01 | −0.09 | 0.00 | |
Price / Book | 0.0x | 2.9x | 2.6x | |
Price / LTM Sales | 0.0x | 10.3x | 3.2x | |
Upside (Analyst Target) | - | 69.2% | 47.6% | |
Fair Value Upside | Unlock | 3.3% | 6.1% | Unlock |
Analyst Ratings
6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 8.2500
(+912.02% Upside)
Earnings
Latest Release
Mar 10, 2026
EPS / Forecast
-0.36 / -0.26
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Skye Bioscience (SKYE) Stock Price Today?
The Skye Bioscience stock price today is 0.8152 USD.
What Stock Exchange Does Skye Bioscience Trade On?
Skye Bioscience is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Skye Bioscience?
The stock symbol for Skye Bioscience is "SKYE."
What Is the Skye Bioscience Market Cap?
As of today, Skye Bioscience market cap is 22.8800M USD.
What Is Skye Bioscience's Earnings Per Share (TTM)?
The Skye Bioscience EPS (TTM) is -1.4100.
From a Technical Analysis Perspective, Is SKYE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Skye Bioscience Stock Split?
Skye Bioscience has split 2 times.
How Many Employees Does Skye Bioscience Have?
Skye Bioscience has 12 employees.
What is the current trading status of Skye Bioscience (SKYE)?
As of Apr 16, 2026, Skye Bioscience (SKYE) is trading at a price of 0.8152 USD, with a previous close of 2.5500 USD. The stock has fluctuated within a day range of 0.7178 USD to 0.8297 USD, while its 52-week range spans from 0.5655 USD to 5.7500 USD.
What Is Skye Bioscience (SKYE) Price Target According to Analysts?
The average 12-month price target for Skye Bioscience is 8.2500 USD, with a high estimate of 20 USD and a low estimate of 2 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +912.02% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.